Cosmos Health Appoints Dr. Iliopoulos to Advisory Board

Cosmos Health Inc. announced the appointment of Dr. Dimitrios Iliopoulos, a globally recognized expert in artificial intelligence, drug discovery, and clinical-stage therapeutic development, to its Advisory Board. Dr. Iliopoulos will support Cosmos Health's biotechnology initiatives, with a specific focus on AI-driven drug discovery and clinical-stage therapeutic development. His extensive background includes co-founding and serving as CEO of Athos Therapeutics Inc., where he developed an AI-driven drug development platform. He also held academic positions at Harvard Medical School and UCLA School of Medicine, where he founded the UCLA Center for Systems Biomedicine. This strategic appointment is aimed at enhancing Cosmos Health's R&D efforts in high-value therapeutic areas such as oncology and autoimmune diseases, leveraging Dr. Iliopoulos's expertise at the intersection of science, clinical execution, and biotech strategy.